Michael Floyd - Oct 6, 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Operating Officer
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Oct 6, 2022
Transactions value $
$0
Form type
4
Date filed
10/11/2022, 09:35 AM
Previous filing
Oct 3, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +12.5K +19.55% 76.4K Oct 6, 2022 Direct F1
transaction PCSA Common Stock Tax liability $0 -4.16K -5.45% $0.00 72.3K Oct 6, 2022 Direct
holding PCSA Common Stock 89.8K Oct 6, 2022 by Elion Oncology, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of restricted stock.